Protective effect of ghrelin on isoniazid-induced liver injury in rat

Protective effect of ghrelin on isoniazid-induced liver injury in rat

Автор: Kheyabany Shadi Sar Kheyr, Nabavizadeh Fatemeh, Vaezi Gholam Hassan, Alizadeh Ali Mohammad, Nahrevanian Hossein, Moslehi Azam, Azizian Saleh

Журнал: Журнал стресс-физиологии и биохимии @jspb

Статья в выпуске: 1 т.9, 2013 года.

Бесплатный доступ

Ghrelin (GHR) is a peptide that has protective effects on many tissues injury. It has anti-inflammatory and anti-oxidant effects. Isoniazid (INH) a widely used antituberculosis drug, has hepatotoxic side effect. The aim of this study was to evaluate the protective role of ghrelin in liver toxicity due to isoniazid. Eighteen male rats were used in this study and divided in to three groups. Including: control, isoniazid, isoniazid and ghrelin groups. Nitric oxide(NO), prostaglandin E2(PGE2), and hepatic enzymes, ALT(alanine aminotransferase), AST(aspartate aminotransferase), ALK(alkaline phosphatas), were assessed and histologic study of liver were performed as indicators of liver damage following isoniazid toxicity. Ghrelin significantly increased NO metabolites and decreased PGE2 level comparison with INH group, but had no significant change compared to the control group. This study showed that ghrelin administration inhibited liver injury in rats due to isoniazid toxicity. The liver protective role of ghrelin may be mediated at least in part by its anti-inflammatory effect.

Еще

Ghrelin, isoniazid(inh), liver injury, nitric oxide(no), prostaglandin e2(pge2)

Короткий адрес: https://sciup.org/14323716

IDR: 14323716

Список литературы Protective effect of ghrelin on isoniazid-induced liver injury in rat

  • Ariyasu, H., Takaya, K., Tagami, T., Ogawa, Y., Hosoda, K., Akamizu, T., et al. (2001). Stomach is a Major Source of Circulating Ghrelin and Feeding State Determines Plasma Ghrelin-Like Immunoreactivity Levels in Humans. Journal of Clinical Endocrinology& Metabolism., 86, 4753-8.
  • Brzozowski, T., Konturek, P., Konturek, S., Kwiecie, S., Drozdowicz, D., Bielanski, W., et al. (2004). Exogenous and endogenous ghrelin in gastroprotection against stress-induced gastric damage. Regulatory Peptides., 120, 39-51.
  • Carlini, V., Monzon, M., Varas, M., Cragnolini, A., Schioth, H., Scimonelli, T., et al. (2002). Ghrelin increases anxiety-like behavior and memory retention in rats. Biochemical and Biophysical Research Communications., 299, 739-743.
  • Date, Y., Kojima, M., Hosoda, H., Sawaguchi, A., Mondal, M., Suganuma, T., et al. (2000). Ghrelin a novel growth hormone-releasing acylated peptide is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology., 141, 4255-61.
  • EI Eter, E., Al Tuwaijiri, A., Hagar, H., Arafa, M. (2007). In vivo and in vitro antioxidant activity of ghrelin: attenuation of gastric ischemic injury in the rat. Journal of Gastroenterology and Hepatology., 22, 1791-1799.
  • Golestan Jahromi, M., Nabavizadeh, F., Vahedian, J., Nahrevanian, H., Dehpour, A.R., Mehrjardi, A.Z. (2010). Protective effect of ghrelin on acetaminophen-induced liver injury in rat. Peptides Journal., 31, 2114-2117.
  • Gonzalez, F.J. (2005). Role of cytochromes P450 in chemical toxicity and oxidative studies with CYP2E1. Mutat. Res., 569: 101-110.
  • Huang, Y.S., Chern, H.D., Chang, S.C., Chiang, C.H., Chang, F.Y., Lee, S.D. (2003). Cytochrome P4502E1 genotype and the susceptibility to antituberculsis drug-induced hepatitis. Hepatology., 37, 924-930.
  • Ishak, K., Baptista, A., Bianchi, L., Callea, F., Gudat, F., Denk, H., Desmet, V., Korb, B., Macsween, R., Philips, M.J., Portmann, B.G., Poulsen, H., Scheuer, P.J., Schmid, M., Thaler, H. (1995). Histological grading and staging of chronic hepatits. J. Hepatology., 22, 696-699.
  • Jaeschke, H., Gores, G., Cederbaum, A., Hinnson, J., Pessayre, D., Lemasters, J. (2002). Mechanisms of hepatotoxicity. Toxicological Sciences. 65, 166-176.
  • James, L., Mayeux, P., Hinson, J. (2003). Acetaminophen-induced hepatotoxicity. Drug Metabolism and Disposition., 31: 1499-1506.
  • Jenner, A.M., Timbrell, J.A. (1994). Influence of inducers and inhibitors of cytochrome P450 on the hepatotoxicity of hydrazine in vivo. Arch Toxicol., 68, 349-357.
  • Khedun, S., Lear, W., Maharai, B., Naicker, T. (1993). Effects of supra-therapeutic doses of isoniazid on liver function in the erfused rat liver. Isr. J. Med., 29, 791-794.
  • Kojima, M., Hosoda, H., Kangawa, K. (2004). Ghrelin a novel growth-hormone-releasing and appetite-stimulating peptide from stomach. Best Practice & Research Clinical Endocrinology & Metabolism., 18, 517-30.
  • Konturek, P., Brzozowski, T., Walter, B., Burnat, G., Hess, T., Hahn, E., et al. (2006). Ghrelin-induced gastroprotection against ischemia-reperfusion injury involves an activation of sensory afferent nerves and hyperemia mediated by nitric oxide. European Journal of Pharmacology., 536, 171-181.
  • Leite-Moreira, A.F., Soares, J.B. (2007). Physiological, pathological and potential therapeutic roles of ghrelin. Drug Discovery Today., 12, 276-288.
  • Li, W.G., Gavrila, D., Liu, X., Wang, L., Gunnlaugsson, S., Stoll, L.L., McCormick, M.L., Sigmund, C.D., Tang, C., Weintraub, N.L. (2004). Ghrelin inhibits proinflammatory responses and nuclear factor-kappa B activation in human endothelial cells. Circulation., 109, 2221-2226.
  • Martinez, F., Abril, E.R., Earnest, D.L., Watson, R.R. (1992). Ethanol and cytokine secretion. Alcohol., 9, 455-458.
  • Maryam, S., Bhatti, A.S.A., Shahzad, A.W. (2010). Protective Effects of Silymarin in Isoniazid Induced Hepatotoxicity in Rabbits. Annals., 16, 43-47.
  • Moreno, M., Chaves, J., Sancho-Bru, P., Ramalho, F., Ramalho, L., Mansego, M., Ivorra, C., Dominguez, M., Conde, L., Millán, C., Marí, M., Colmenero, J., Lozano, J.J., Jares, P., Vidal, J., Forns, X., Arroyo, V., Caballería, J., Ginès, P., Bataller, R. (2010). Ghrelin attenuates hepatocellular injury and liver fibrogenesis in rodents and influences fibrosis progression in humans. Hepatology., 51, 974-85.
  • Nahrevanian, H., Hajihosseini, R., Arjmand, M., Farahmand, M., Ghasemi, F. (2009). Evaluation of anti-leishmanial activity by induction of nitric oxide and inhibition of prostaglandin in Balb/c mice infected with leishmania major. Southeast Asian Journal of Tropical Medicine and Public Health., 40(6), 1188-1198.
  • Nolan, C.M., Goldberg, S.V., Buskin, S.E. (1999). Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis Clinic. JAMA., 281, 1014-1018.
  • Samuel, M.P., Michael, A.T., Danielle, I.P., Robert, B.R., Wen, X., Reginald, F.F., Michael, A.Z. (2004). The effect of isoniazid on CYP2E1-and CYP4-Mediated hydroxylation of Arachidonic acid in the rat liver and kidney. Drug Metabolism and Disposition., 32, 727-733.
  • Sarich, T.C., Adams, S.P., Petricca, G, Wright, J.M. (1999). Inhibition of isoniazid induced hepatotoxicity in rabbits by pretreatment with an amidase inhibitor. J Pharmacol Exp Ther., 289, 695-702.
  • Self, T.H., Chrisman, C.R., Baciewicz, A.M., Bronze, M.S. (1999). Isoniazid drug and food interactions. AM. J. Med Sci., 317, 304-311.
  • Shen, C., Zhang, H., Zhang, G., Meng, Q. (2006). Isoniazid-induced hepatotoxicity in rat hepatocytes of gel entrapment culture. Toxicol. Lett., 167, 66-74.
  • Shiiya, T., Nakazato, M., Mizuta, M., Date, Y., Mondal, M., Tanaka, M., Nozoe, S., Hosoda, H., Kangawa, K., Matsukura, S. (2002). Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. Journal of Clinical Endocrinology & Metabolism., 87, 240-4.
  • Sibilia, V., Rindi, G., Pagani, F., Rapetti, D., Locatelli, V., Torsello, A., Campanini, N., Deghenghi, R., Netti, C. (2003). Ghrelin protects against ethanol-induced gastric ulcers in rats: studies on the mechanism of action. Endocrinology., 144, 353-359.
  • Tesauro, M., Schinzari, F., Iantomo, M., Rizza, S., Melina, D., Lauro, D., Cardillo, C. (2005). Ghrelin improves endothelial function in patients with metabolic syndrome. Circulation., 112, 2986-2992.
  • Timbrell, J.A., Mitchell, J.R., Snodgrass, W.R., Nelson, S.D. (1980). Isoniazid hepatoxicity: the relationship between covalent binding and metabolism in vivo. J. Pharmacol. Exp. Theor., 213, 364-369.
  • Vuilleumier, N., Rossier, M.F., Chiappe, A., Degoumois, F., Dayer, P., Mermillod, B., Nicod, L., Desmeules, J., Hochstrasser, D. (2006). CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis. Eur. J. Clin. Pharmacol., 62, 423-429.
  • Weber, W.W., Hein, D.W. (1979). Clinical pharmacokinetics of isoniazid. Clin Pharmacokinet., 4, 401-422.
  • Weikel, J., Wichniak, A., Ising, M., Brunner, H., Friess, E., Held, K., Mathias, S., Schmid, D.A., Uhr, M., Steiger, A. (2003). Ghrelin promotes slow-wave sleep in humans. American Journal of Physiology-Endocrinology and Metabolism., 284, 407-15.
  • Whitehouse, L.W., Tryphonas, L., Paul, C.J., Solomonraj, G., Thomas, B.H., Wong, L.T. (1983). Isoniazid-induced hepatic steatosis in rabbits: an explanation for susceptibility and its antagonism by pyridoxine hydrochloride. Can. J. Physiol. Pharmacol., 61, 478-487.
  • Yada, T., Kaiya, H., Mutoh, K., Azuma, T., Hyodo, S., Kangawa, K. (2006). Ghrelin stimulates phagocytosis and superoxide production in fish leukocytes. Journal of Endocrinology., 189, 57-65.
  • Yoshihara, F., Kojima, M., Hosoda, H., Nakazato, M., Kangawa, K. (2002). Ghrelin: a novel peptide for growth hormone release and feeding regulation. Current Opinion in Clinical Nutrition & Metabolic Care., 5, 391-5.
  • Young, T.H., Tang, H.S., Chao, Y.C., Lee, H.S., Hsiong, C.H., Pao, L.H., Hu, O.Y.P. (2008). Quantitative rat liver function test by galactose single point method. Laboratory Animals., 42, 495-504.
  • Yue, J., Dong, G., He, C., Chen, J., Liu, Y., Peng, R. (2009). Protective effects of thiopronin against isoniazid-induced hepatotoxicity in rats. Toxicology., 264, 185-191.
Еще
Статья научная
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp